Adipose-derived mesenchymal stem cell secretome demonstrates measurable regenerative effects in chemically damaged testicular tissue, with vascular endothelial growth factor (VEGF) identified as the key therapeutic mediator. Across three murine studies using busulfan, doxorubicin, or acrylamide injury models, secretome treatment restored seminiferous tubule architecture, increased Leydig cell numbers, reduced cellular apoptosis, and elevated testosterone levels compared to controls. The therapeutic effect was completely abolished when VEGF was blocked, confirming its mechanistic importance. This cell-free approach represents a potentially significant advancement in reproductive medicine, offering a more accessible alternative to direct stem cell transplantation for treating male infertility. The finding is particularly relevant given that male factors contribute to 50% of couple infertility cases globally, and sperm quality continues declining. However, the evidence base remains extremely limited with only three preclinical studies, all using animal models with artificially induced chemical damage. The translation to human male infertility, which typically involves complex multifactorial causes rather than acute chemical injury, remains speculative. While promising for regenerative urology, this approach requires extensive human trials before clinical application.